Astellas Steps Tentatively Into Global Vaccines, Following Path Of Japanese Competitors
This article was originally published in PharmAsia News
Executive Summary
Astellas Pharma Inc. is making forays into the vaccines segment, with the support of development firm ClearPath Development Company to accelerate the process.